Introduction {#s1}
============

Disentangling the role between goal-directed and habitual systems of behavioral control and how the neurotransmitter serotonin (5-HT) contributes to this is clinically important. Under normal conditions, human behavior can be flexible and adaptive, with actions directed by the value of the outcome in terms of goal-directed behaviors. When needed, more mechanistic and automatic responses to contextual cues can be elicited by stimulus-response actions, which are insensitive to goal value. The balance of both systems is crucial for correct instrumental learning ([@CIT0006]; [@CIT0019]). Deficits in the balance of behavioral control between goal-directed and habit processes may lead to psychological problems such as drug addiction, schizophrenia, or obsessive-compulsive disorder. These systems can be distinguished experimentally by devaluing the reinforcer after an instrumental response has been learned and evaluating the frequency of responses to the devalued reinforcer using an instrumental discrimination task developed by [@CIT0005].

Previous studies have yielded contradictory results about the interaction of dopamine (DA) and 5-HT in this balance. It has been suggested that DA biases behavior towards habitual responding, with 5-HT offsetting this phenomenon and directing the balance toward more flexible, goal-directed responding. However, previous research in animals and humans suggests roles for DA in both goal-directed and habitual action ([@CIT0007]). Furthermore, 5-HT has been implicated in punishment and behavioral inhibition and, more specifically, a reduced incentive motivation when 5-HT is low ([@CIT0018]; [@CIT0004]; [@CIT0009]). Therefore, the relative and multiple roles of DA and 5-HT in the balance of goal-directed and habitual responding are unclear.

The paper by [@CIT0020], which was recently published in this journal, focuses on the effects of acute tryptophan (TRP) depletion (ATD), a neurodietary physiological method to decrease central nervous 5-HT synthesis in humans for a short period of time, on the balance between hypothetical goal-directed and habitual systems. In this particular study conducted in healthy adult volunteers, a short-term serotonergic deficit induced by ATD was associated with a shift of behavioral performance towards habitual responding, the magnitude of which was predicted by a steeper decline in plasma levels of TRP, the physiological precursor amino acid of 5-HT. This finding is of particular relevance, as it shows that central nervous 5-HT function modulates the balance between goal-directed and stimulus-response habitual systems of behavioral control. In particular, [@CIT0020] used the de Wit methodology to disentangle the role of 5-HT in goal-directed vs habitual action with careful controls for its other actions. They used ATD, which is a widely used translational research method, to lower serotonergic function with a TRP-deficient beverage ([@CIT0022]; [@CIT0002]; [@CIT0017]). The authors showed that after an ATD challenge, subjects increased responding for devalued stimuli during the slip-of-action stage, indicating a devaluation of the outcome without changes in response-outcome learning. This effect implies a shift in the balance of action toward habitual responding during ATD. One useful feature of the present study was the use of several controls for other potential actions of 5-HT. No differences for valuable outcomes were found between groups, in contrast to previous reports suggesting insensitivity to reward value after pharmacological 5-HT reduction ([@CIT0016]; [@CIT0015]). Furthermore, ATD had no effect during a control test of response disinhibition, while other studies indicated a dual role of 5-HT in negative affect and behavioral inhibition ([@CIT0004]).

However, various studies suggest that altered DA function during ATD could have contributed to the present results. Both animal ([@CIT0021]; [@CIT0008]) and human studies including those from the same laboratory have shown dopaminergic contribution to habit control. Recent findings from our laboratory indicate that ATD has the potential to influence both 5-HT and DA. [@CIT0017] in a mouse study showed that ATD not only impaired serotonergic function as previously described, but also lowered tyrosine (a semi-essential amino acid precursor of DA) and homovanillic acid (major end-product of DA metabolism). This finding suggests that nonserotonergic effects of ATD might contribute to its behavioral effects. The potential specificity of these formulations was previously questioned ([@CIT0001]). Future studies will hopefully explore the role of catecholaminergic function in this important type of behavioral control.

The impact of a short-term reduction in central nervous 5-HT synthesis by means of ATD on behavioral characteristics has been the subject of many studies (eg, see [@CIT0002]; [@CIT0003]; [@CIT0017]). In particular, the effects of ATD on aggressive and impulsive behaviors and related behavioral constructs such as behavioral inhibition have attracted much attention. A recent study from our group on the underlying neural correlates of impulsivity in adult female volunteers combined the Moja-De ATD methodology with functional neuroimaging techniques employing a modified Go/No-Go task that implements punishment and reward ([@CIT0010]). In this particular study, neural activation during No-Go trials in punishment conditions was positively correlated with ATD-related depletion magnitude in the ventral and subgenual anterior cingulate cortices (ACC), and neural activation in the medial orbitofrontal cortex and the dorsal ACC were also positively correlated with baseline impulsivity ([@CIT0010]). Neural sensitivity to punishment after ATD administration in brain areas known to be associated with emotion regulation increased with depletion magnitude and in brain areas related to appraisal and expression of emotions (medial orbitofrontal cortex and dorsal ACC), increasing with baseline impulsivity ([@CIT0010]). These findings support the conclusion that 5-HT modulates neural circuits related to impulsive behaviors, emotion regulation, and punishment processing, and the found effects somewhat map on the found relationship between depletion magnitude and the tendency detected by [@CIT0020] towards habitual responding.

Conclusion {#s2}
==========

Studying the effects of other neuropharmacological challenge tests such as TRP enhancement (ie, within a loading paradigm) on both goal-directed and habit behavior could help to verify the role of 5-HT with regard to the outlined behaviors. Understanding the complex role of 5-HT and DA is crucial with regard to their critical position in the underlying neurobiology of neuropsychiatric disorders. In this context, the paper by [@CIT0020] published in this journal relates to a component of the OCD clinical syndrome, namely a shift from goal-directed to habit-based behavior, that is sensitive to acute serotonergic manipulation that previous ATD in OCD studies have not examined or elicited. Future analysis of this variable might provide similar insights in related disorders with compulsive behavioral components, such as eating disorders ([@CIT0012], [@CIT0013]) and substance addiction ([@CIT0014]).
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